Donga Socio Holdings

Dong-A Socio Holdings Co., Ltd. is a South Korean company engaged in the pharmaceutical business together with its subsidiaries. It operates through segments including Holding Company; Over-the-Counter Drugs and Quasi-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others. Its pipeline includes DA-8010 in Phase 3 for overactive bladder, DMB-3115 (a Stelara biosimilar) in Phase 3, DA-1241 in Phase 2 for non-alcoholic steatohepatitis, DA-1726 in Phase 1 for obesity, and STP0404 for AIDS. The company also offers medical devices, healthcare solutions, health functional foods, CDMO services, POCARI SWEAT sports drinks, logistics and fulfillment, packaging materials, beverages, and IT and construction services. Founded in 1932, it is headquartered in Seoul, South Korea.